Pancreatic Cancer Research

ResearcherUniversity of ZurichNo recent work listed

Hanns Möhler

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5106235440. Sources: OpenAlex.

Their work

Papers
1 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2023: 1 paper

Papers 1

  1. GP-2250, a novel anticancer agent, inhibits the energy metabolism, activates AMP-Kinase and impairs the NF-kB pathway in pancreatic cancer cells. Last author DOI 10.1111/jcmm.17825↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marie Buchholz · 1 shared paper, 2023 · strength 0.17
  2. Britta Majchrzak‐Stiller · 1 shared paper, 2023 · strength 0.17
  3. Waldemar H. Uhl · 1 shared paper, 2023 · strength 0.17
  4. Stephan A. Hahn · 1 shared paper, 2023 · strength 0.17
  5. Chris Braumann · 1 shared paper, 2023 · strength 0.17
  6. Philipp Höhn · 1 shared paper, 2023 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.